Purchase Order 75N95024P00586

Award Date 9/9/24
Potential Completion Date 9/8/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St Peters, MO 63304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a $401,178.36 firm fixed-price delivery order to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract is for receptor profiling and predictive toxicology services to support NIDA's research initiatives. This task order was issued under a larger $5 million IDIQ contract from NIDA for receptor binding services, which includes...
This is a firm fixed-price delivery order issued by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $359,131 order is for a 1-year period of performance from September 30, 2020 to September 29, 2021 under the NIDA N01DA-18-8937 contract vehicle. The work involves receptor binding and predictive toxicology services to support NIDA's drug...
This is a $142,193 cost-plus-fixed-fee task order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The task order is for receptor binding and predictive toxicology services to support drug discovery research, with a period of performance from September 26, 2023 to September 25, 2024. Eurofins...
The federal contract award is for $300,609.00 and was granted to Eurofins Discovery Services North America, LLC, a foreign-owned, for-profit contract research organization. The award is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the National Institute on Drug Abuse (NIDA), a part of the U.S. Department of Health and Human Services. The contract is for receptor profiling and predictive toxicology services, specifically receptor binding studies, safety...
This is a $132,771.58 firm-fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The contract is for receptor profile screening services in support of NIDA's drug abuse research programs. It has a period of performance from June 25, 2025 to June 24, 2026. The contract is not set aside for any small...
This is a task order award under the National Institute on Drug Abuse's (NIDA) IDIQ contract No. HHSN271201800024I for receptor binding and predictive toxicology services. The award, valued at $291,884.01, was issued to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The task order is for work described under the NIDA contract with a period of performance from April 3, 2020 to April 2, 2021. The contract was awarded on a firm-fixed-price...
This is a federal contract award by the Department of Health and Human Services' National Institutes of Health, National Institute on Drug Abuse, to Eurofins Panlabs, Inc. The contract is for receptor binding and predictive toxicology services, with a potential value of $446,504.00. The contract was awarded on March 22, 2019, and has a completion date of March 21, 2020. Eurofins Panlabs, Inc. is a foreign-owned, for-profit contract research organization that provides analytical chemistry,...
This is a firm fixed price delivery order issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse, to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $224,328 task order is for receptor binding and predictive toxicology services under an existing indefinite delivery/indefinite quantity (IDIQ) contract, HHSN271201800024I. No set-aside was used. Eurofins Panlabs has a history of...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The $22,869.00 firm fixed-price purchase order was awarded to Eurofins Discoverx LLC, a foreign-owned for-profit organization that specializes in providing cell-based assays, reagents, and services to support drug discovery and development research. The purpose of this contract is to conduct a kinase panel screening of 25 small...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for $301,894.16 in firm fixed-price services related to testing lead compounds for additional characterization and reagent development. The contract does not have a set-aside designation. Eurofins Discoverx Corporation is a provider of innovative cell-based...

The U.S. National Institute on Drug Abuse (NIDA) has awarded a firm-fixed-price purchase order contract worth $20,217.10 to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract, which does not have a set-aside designation, is for the provision of various research and development services to support NIDA's drug abuse research programs. These services include receptor binding studies, predictive toxicology, safety pharmacology, and non-clinical research.

Eurofins Panlabs has received multiple federal contract awards from agencies such as the NIH, EPA, FDA, and VA to provide analytical chemistry, microbiology, and toxicology testing services. The company holds several significant federal contract indefinite delivery vehicles (IDVs) with the FDA, NIDA, and EPA, demonstrating its critical role in supporting research and development across various government agencies.

Generated 9/10/24, 9:09 AM